Navigation Links
Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments

Individuals with moderate to severe chest pains (angina) who have not found relief from medication may benefit from a new gene therapy approach being used by cardiologists at Rush University Medical Center to grow new blood vessels in the heart.

The phase II clinical research study uses vascular endothelial growth factor-2 (VEGF-2) in the form of a solution containing a DNA plasmid that is delivered using catheterization to heart tissue that has been damaged from insufficient blood flow.

Once the catheter reaches the targeted site inside of the heart, the VEGF-2 is injected into the heart muscle region with inadequate blood supply. The DNA plasmid is then taken up by the middle muscular layer of the heart wall near the injection site. Inside the cell, the DNA encoded VEGF-2 expresses itself which in turn stimulates the growth of new blood vessels by promoting the proliferation of endothelial cells in the heart.

New blood vessels are required to provide oxygen-carrying blood to heart muscles to compensate for the blocked heart arteries. The subsequent, improved blood flow relieves the painful symptoms of angina.

"The process of growing new blood vessels, or angiogenesis, should occur over the course of four to eight weeks following the procedure which is done in the cardiac catheterization lab at Rush," said Dr. Gary L. Schaer, the principal investigator of the trial at Rush and director of the Rush Cardiac Catheterization Labs. "The patient goes home the next day." Several patients have received the gene therapy and all are doing well.

Individuals who may be candidates for this gene therapy study trial must have moderate to severe angina, but cannot also be candidates for treatment using angioplasty or bypass surgery. Angioplasty involves a catheterization with a balloon-like device that opens blocked arteries, while bypass surgery requires open-heart surgery to place veins removed from the patient's leg or arteries taken from
'"/>

Source:Rush University Medical Center


Page: 1 2

Related biology news :

1. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
2. Researchers Closer To Helping Hearing-Impaired Using Stem Cells
3. Using nanoparticles, in vivo gene therapy activates brain stem cells
4. Using computers and DNA to count bacteria
5. Using the genomic shortcut to predict bacterial behavior
6. Using natures most primitive anti-viral defense system to find new approaches to cancer research
7. Using dental X-rays to detect osteoporosis
8. Using brain scans, researchers find evidence for a two-stage model of human perceptual learning
9. Using nanomagnets to enhance medical imaging
10. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
11. Novel Therapy Tested in Mice Could Chase Away Cat Allergies

Post Your Comments:
(Date:11/5/2009)...logy Teachers (NABT) will recognize Leonard C. Yan...uck Valley Community College (NVCC) in Waterbury, ...rd during the NABT annual professional development...er, Colorado. , The Evolution Education Award is...al Sciences,(AIBS) and Biological Sciences Curric...
(Date:11/5/2009)...awarded a training grant in the amount of $2,756,7...tegrative Graduation Education and Research Traini...to be awarded to Kent State. The grant, which is f... Act of 2009, runs through 2014. , The grant fun...uatic resource sensing (EARS). The purpose of the ...
(Date:11/4/2009)...science) , United States Using Less Water Toda...n it did 35 years ago, despite a 30 percent popula...tributable to alternative cooling methods at power...ording to the latest USGS water use report, nearly...to cooling thermoelectric power plants. Irrigation...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Womens Sexual Health Issues Hit Home 50111 1Womens Sexual Health Issues Hit Home 50111 2Colin Powell Applauds Lions for Leadership in Volunteerism as Interest in Volunteer Service Grows 50108 1Colin Powell Applauds Lions for Leadership in Volunteerism as Interest in Volunteer Service Grows 50108 2Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 1Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 2Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 3Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 4Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 5Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 6
...biological processes; it is an active participant....in which the actions of the solvent play a key rol...ing processes has been on observation of the prote...y Martin Gruebele and Martina Havenith have now be...ork during protein folding in real time. As they r...
...y, using electric pulses to destroy cancer tissue ...technological breakthroughs of 2007, is receiving ...o the marketplace. One of its lead developers, Ra...TechWake Forest University School of Biomedical En... grant from the Wallace H. Coulter Foundation and ...
... to Provide Integrated Fingerprint ... Technology, an award-winning,fingerprint biometri...that,Harms Software, a leading provider of managem...reed to begin providing M2SYS fingerprint readers ... Software has successfully integrated M2SYS, Bio-P...
Other Biology News:Keeping an eye on the surroundings 2Commercialization aim of grant supporting technology that destroys cancer cells 2M2SYS Technology Innovative Fingerprint Biometrics Solution Chosen by Harms Software 2
(Date:11/6/2009)..., SAN MATEO, Calif., Nov. 6 /PRNewswire-First..., Completed transfer of Qutenza(TM) E.U. Marketi...Made significant progress in commercial readiness ... Sales; Senior Director, Marketing; and Director, ...in to board as director and Audit Committee chairm...
(Date:11/5/2009)..., , TRANSPORTATION -- Gone hybrid . . . , Fu...omobiles are now posted at the www.fueleconomy.go...eveloped and maintains for the U.S. Department of ...y. Nine of the top 10 vehicles on the best fuel ec... Prius (51 MPG city; 48 highway). "This list prove...
(Date:11/5/2009)..., RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-..., a leading supplier of innovative products for pr...ted results for the first quarter of fiscal 2010. ...e Company reported revenues of $5.2 million, a 15 ...the first quarter a year ago. The Company said the...
(Date:11/5/2009)..., FORT WORTH, Texas, Nov. 5 /PRNewswire-First...M), announced today that it has entered into a Let...ssets of Virtual Health Technologies, Inc. (OTC Bu... be paid $1,000,000 in cash and debt, 4,000,000 sh...generated by WNDM on the Veriscrip technology bein...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...ement of Longer-term Phase 2 Switching Study, CRA...harmaceutical company developing small-molecule, o...the treatment of human genetic diseases,announced ...ts from a Phase,2 clinical study of Plicera(TM) (i...erican College of Medical Genetics (ACMG) Annual M...
...ist on the strangeness of the nanoworld, researche...nology (NIST) and the University of Maryland-Colle...ica that are quite brittle in bulk form behave as ...y affect the design of future nanomachines. , NIS... colleagues first demonstrated* the latest incongr...
... Calif., March 12 ,Exelixis, Inc. (Nasdaq: EXEL )...dent and chief executive officer of Exelixis, will...re Conference at 4:00 p.m. ET / 1:00 p.m.,PT on Mo...ates to the,company,s development pipeline and cor...t and may be accessed in the Event,Calendar page u...
Other Biology Technology:Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease 2Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease 3Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease 4Nanomaterials show unexpected strength under stress 2
Lipofectin Reagent from Invitrogen
Chicken Anti-Human ADI1 Polyclonal Antibody, Unconjugated from Abcam
GIBCO Dulbeccos Phosphate-Buffered Saline (D-PBS) (1X); liquid Contains calcium and magnesium from Invitrogen
Mouse Anti-JNK2 Antibody, Unconjugated from Upstate
Biology Products: